Our results suggest that serum anti-C1q antibody is more strongly associated with renal disease activity in SLE patients than anti-dsDNA antibodies and reduction of C3 and C4 in terms of diagnostic specificity. The gene discussed is C4A; the disease is systemic lupus erythematosus.